DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

The DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award aims to promote evidence-based and patient-centered approaches to improve health and lung cancer-related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category. • This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver. • This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials. • The estimated funding for this award is $1,950,000. • The award is expected to support 2 projects.